{"id":"CVE-2026-21974","aliases":["EUVD-2026-3538","GHSA-vpg5-x373-3q2c"],"status":"published","title":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences...","description":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer.  Successful attacks of this vulnerability can result in  unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).","severity":{"version":"3.1","score":5.3,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N","level":"medium","assessor":"cna","from":"cve"},"epss":{"day":"2026-11-10","score":0.00255,"percentile":0.17203,"model":"v2026.06.15"},"facts":{"in_kev":false,"known_exploited":false,"public_exploit":false,"fix_available":false},"cwes":["CWE-200"],"published":"2026-01-20T21:56:36Z","modified":"2026-06-17T10:19:15Z","products":[{"vendor":"oracle","product":"life_sciences_central_designer"},{"vendor":"oracle corporation","product":"oracle life sciences central designer"}],"references":[{"url":"https://www.oracle.com/security-alerts/cpujan2026.html","tags":["vendor-advisory","Vendor Advisory"]},{"url":"https://nvd.nist.gov/vuln/detail/CVE-2026-21974"},{"url":"https://github.com/advisories/GHSA-vpg5-x373-3q2c"}],"sources":{"cve":[{"id":"CVE-2026-21974","description":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer.  Successful attacks of this vulnerability can result in  unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).","status":"published","published":"2026-01-20T21:56:36.617Z","modified":"2026-01-21T14:38:13.502Z","cvss":[{"version":"3.1","score":5.3,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N","level":"medium","assessor":"cna"}],"cwes":["CWE-200"],"updated_at":"2026-11-02T13:41:42.05254Z"}],"euvd":[{"id":"EUVD-2026-3538","description":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer.  Successful attacks of this vulnerability can result in  unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).","status":"published","published":"2026-01-20T21:56:36Z","modified":"2026-01-21T14:38:13Z","cvss":[{"version":"3.1","score":5.3,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N","level":"medium"}],"updated_at":"2026-11-02T19:48:49.964072Z"}],"ghsa":[{"id":"GHSA-vpg5-x373-3q2c","title":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences...","description":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer.  Successful attacks of this vulnerability can result in  unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).","status":"published","published":"2026-01-21T00:31:43Z","modified":"2026-01-21T15:32:23Z","cvss":[{"version":"3.1","score":5.3,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N","level":"medium"}],"cwes":["CWE-200"],"updated_at":"2026-11-02T15:05:50.116831Z"}],"nvd":[{"id":"CVE-2026-21974","description":"Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer.  Successful attacks of this vulnerability can result in  unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).","status":"published","published":"2026-01-20T22:16:00.587Z","modified":"2026-06-17T10:19:15.84Z","cvss":[{"version":"3.1","score":5.3,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N","level":"medium","assessor":"secondary"}],"cwes":["CWE-200"],"updated_at":"2026-11-02T14:12:04.423757Z"}]}}